HIV Research in the Era of PrEP: The Implications of TDF/FTC for Biomedical Prevention Trials

Recommendations on the provision of pre-exposure prophylaxis (PrEP) in HIV prevention trials, based on a review of the scientific literature and a survey of community-based advocates (including members of the advisory boards of such trials), are summarised in this white paper.

External Links: 
HIV Research in the Era of PreP: The Implications of TDF/FTC for Biomedical Prevention Trials
Length: 
17 pages
Year: 
2017
Organization: 
Treatment Action Group
Languages: 
English
Author(s): 
Jeffreys R, Horn T, Johnson J
Tags: 
PrEP
pre-exposure prophylaxis
standard of prevention